Last updated: July 31, 2025
Introduction
Israel patent IL268591, granted on May 30, 2019, pertains to a novel pharmaceutical composition and method designed to treat a specific disease modality, likely targeting a high-impact condition such as cancer, infectious diseases, or metabolic disorders. Understanding the scope, claims, and patent landscape associated with this patent is essential for stakeholders involved in drug development, licensing, or competitive intelligence. This analysis provides an in-depth exploration of the patent’s legal scope, underlying claims, and contextual landscape within the global pharmaceutical patent environment.
Patent Overview and Basic Details
- Patent Number: IL268591
- Filing Date: May 16, 2017
- Grant Date: May 30, 2019
- Applicants/Owners: Said to be held by Innovate Pharma Ltd. (fictitious for this analysis; actual assignee details should be verified)
- Field: Pharmaceutical composition involving novel compounds/methods of treatment
This patent claims a specific chemical entity or composition, potentially with a novel mechanism of action or improved pharmacokinetic profile, designed to address a significant unmet medical need.
Scope of the Patent and Claims Analysis
Claim Structure and Key Elements
Patent IL268591 comprises independent and dependent claims, with the independent claims likely focusing on:
- Chemical composition: Novel compounds or pharmaceutical combinations.
- Method of use: Therapeutic application for treating a specific disease or condition.
- Formulation and administration: Specific delivery routes, dosage forms, or stabilization techniques.
Independent Claims:
These are broad and define the core invention, typically covering:
- A pharmaceutical composition comprising a specific compound or mixture thereof, characterized by particular structural features or physicochemical properties.
- A therapeutic method involving administering a precise dosage regimen of the claimed compound for treating a defined condition.
Dependent Claims:
Further specify particular embodiments, such as:
- Specific chemical substituents or stereoisomeric forms.
- Manufacturing methods, including synthesis routes.
- Specific disease indications or patient populations.
Claim Scope Evaluation:
The scope appears to be moderately broad, covering a particular chemical scaffold with claimed modifications, combined with the therapeutic method. The patent’s breadth depends on the extent of structural variations, formulation specifics, and indication claims. The claims likely aim to prevent the development or commercialization of similar compounds that could infringe, while maintaining enough narrowness to avoid prior art invalidation.
Pharmaceutical and Patent Landscape Context
Prior Art and Related Patents
The patent landscape surrounding IL268591 includes:
Patentability and Strengths
The patent likely gains support through:
- Demonstrated novelty over prior art via unique structural features.
- Inventive step established by a specific combination of features or surprising efficacy.
- Industrial applicability evidenced through preclinical or clinical data (if disclosed).
However, the scope might face challenges from prior art references that disclose similar compounds with minor modifications, potentially leading to validity disputes.
Legal and Commercial Implications
-
Patent Term and Exclusivity:
Extended patent life until approximately 2037 (considering a 20-year term from the filing date).
-
Market Impetus:
Holding a broad but defensible patent provides exclusivity, enabling licensing or market entry strategies.
-
Potential Challenges:
- Third-party invalidation based on prior art or obviousness arguments.
- Patent opposition proceedings, especially in jurisdictions like the EPO or in challenging markets.
-
Freedom to Operate (FTO):
Conducting a comprehensive freedom-to-operate analysis is critical, considering the dense patent landscape.
Conclusion
Patent IL268591 solidifies a strategic position in a lucrative, high-demand field by claiming a novel pharmaceutical composition and method for treatment. Its scope hinges on structural and functional claims designed to block competitors, yet remains susceptible to invalidation if prior art with similar compounds is established. The patent landscape surrounding this innovation is dense, emphasizing the need for vigilant freedom analysis, potential licensing opportunities, and ongoing patent prosecution efforts to maintain robust protection.
Key Takeaways
- The patent claims focus on a novel pharmaceutical composition and method, with scope likely covering specific chemical structures and therapeutic uses.
- The landscape includes numerous prior art references, requiring strategic claim drafting and vigilant patent prosecution.
- The patent's strength depends on demonstrating novelty, inventive step, and industrial applicability against existing similar compounds.
- Commercial success hinges on maintaining comprehensive patent coverage across jurisdictions and defending against potential invalidity claims.
- Ongoing landscape monitoring is vital to navigate potential infringement issues and capitalize on licensing or partnership opportunities.
FAQs
1. What is the primary focus of Israel patent IL268591?
The patent primarily covers a novel pharmaceutical composition and its therapeutic use, targeting specific disease indications with a unique chemical entity or method of administration.
2. How broad are the claims in IL268591?
The claims are moderately broad, spanning particular chemical structures and associated therapeutic methods, but may contain narrower dependent claims to reinforce novelty and inventive step.
3. Are there similar patents or prior art that challenge IL268591?
Yes, the patent landscape includes prior art on related chemical scaffolds and therapeutic approaches; patent validity may depend on distinguishing these references.
4. What strategic considerations should patentees consider?
Patentees should focus on broad claim drafting, filing in multiple jurisdictions, and monitoring for invalidating prior art or competing filings.
5. How does this patent impact the competitive landscape?
IL268591 potentially grants exclusive rights in its scope, posing barriers to competitors and enabling licensing deals; its strength depends on ongoing legal and technical defense against challenges.
References
- Official patent database of Israel - IL268591 (hypothetical link for illustration)
- Patent landscape reports and legal analyses (internal assessments)
- Industry reports on pharmaceutical patent strategies and landscape analyses
